ArticleFood science & nutrition2025
Fenugreek Sprouts Around the World: Exploring Therapeutic and Nutritional Benefits.
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- β-carotene enhances drought tolerance in fenugreek by modulating antioxidant defense and redox homeostasis.Plant signaling & behavior · 2026Article
- The effect of fenugreek (Trigonella foenum-graecum) on stallion spermatozoa motility and vitality in vitro.Veterinary research communications · 2026Article
- Therapeutic potential of medicinal plant sprouts: emerging opportunities and challenges in phytochemistry.Planta · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigates the therapeutic and nutritional potential of fenugreek sprouts from 30 diverse genotypes sourced from various regions. The aim was to characterize and compare their therapeutic attributes, including antioxidant capacity, antidiabetic, and anti-cholinesterase activities, along with their nutritional compositions, particularly minerals, and protein content. Results revealed significant variations among the genotypes in terms of their therapeutic properties. China genotypes exhibited notable α-amylase inhibition 64.57%, suggesting potential antidiabetic properties, while South Sudan genotypes demonstrated significant acetylcholinesterase (14.44%) and butyrylcholinesterase inhibitions, indicating possible cognitive health benefits. The Morocco and Konya/Türkiye genotypes exhibited noteworthy antioxidant effects, with showing DPPH
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.